Journal
FUTURE MICROBIOLOGY
Volume 9, Issue 4, Pages 457-463Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/FMB.14.10
Keywords
antimicrobial resistance; flagella; ICU; lipopolysaccharide; outer membrane proteins; pneumonia; Pseudomonas; sepsis; vaccination
Categories
Ask authors/readers for more resources
Pseudomonas aeruginosa is one of the most common causes of nosocomial infection in intensive care unit patients and is independently associated with worse outcomes. Resistance of P. aeruginosa to antimicrobial agents is increasingly common and treatment of these infections is a growing challenge for intensivists. The development of methods to prevent infection, such as vaccines, is thus of considerable interest. Three agents currently show promise in this population of patients and are undergoing clinical evaluation; however, further vaccine targets are being discovered and more potential agents will likely be developed in the near future.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available